Drop in COVID Cases Seen in Nursing Homes as U.S. Vaccine Effort Makes Headway
The Pharma Data
FEBRUARY 1, 2021
Two widely anticipated new COVID-19 vaccines — from Johnson & Johnson and Novavax — appear to halt infections in places where more contagious variants are circulating, new trials show. The more infectious British variant was found to have caused about 50 percent of the cases in that trial, Novavax said.
52 
Let's personalize your content